G. Greim

521 total citations
8 papers, 429 citations indexed

About

G. Greim is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, G. Greim has authored 8 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 1 paper in Organic Chemistry. Recurrent topics in G. Greim's work include Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). G. Greim is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). G. Greim collaborates with scholars based in Germany, Netherlands and Switzerland. G. Greim's co-authors include J. Wanders, P. Fumoleau, Aarón Sulkes, Patrick Schöffski, Kasper van der Born, Godefridus J. Peters, Ronald de Wit, M. Borner, Francesco Caponigro and Christophe Martin and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Naunyn-Schmiedeberg s Archives of Pharmacology.

In The Last Decade

G. Greim

8 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Greim Germany	5	261	109	102	64	40	8	429
Lynn Adams United States	8	209 0.8×	80 0.7×	95 0.9×	52 0.8×	36 0.9×	9	376
K. Weigang-Köhler Germany	11	401 1.5×	113 1.0×	222 2.2×	83 1.3×	112 2.8×	13	555
Wayne D. Brenckman United States	12	147 0.6×	146 1.3×	70 0.7×	45 0.7×	22 0.6×	15	441
John A. Benvenuto United States	14	279 1.1×	226 2.1×	76 0.7×	28 0.4×	58 1.4×	33	589
A Setanoians United Kingdom	12	253 1.0×	316 2.9×	62 0.6×	37 0.6×	97 2.4×	15	588
F. Merlin Italy	8	167 0.6×	112 1.0×	72 0.7×	60 0.9×	70 1.8×	18	504
Laura Milesi Italy	9	256 1.0×	132 1.2×	95 0.9×	77 1.2×	89 2.2×	16	475
Sandra R. B. Allerheiligen United States	11	215 0.8×	186 1.7×	107 1.0×	40 0.6×	42 1.1×	16	586
Judit Kralovánszky Hungary	15	266 1.0×	138 1.3×	98 1.0×	70 1.1×	71 1.8×	49	511

Countries citing papers authored by G. Greim

Since Specialization

Citations

This map shows the geographic impact of G. Greim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Greim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Greim more than expected).

Fields of papers citing papers by G. Greim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Greim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Greim. The network helps show where G. Greim may publish in the future.

Co-authorship network of co-authors of G. Greim

This figure shows the co-authorship network connecting the top 25 collaborators of G. Greim. A scholar is included among the top collaborators of G. Greim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Greim. G. Greim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Greim, G., Markus Borner, K. Weigang-Köhler, et al.. (2002). Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration. European Journal of Cancer. 38(8). 1072–1080. 57 indexed citations

Sessa, Cristiana, K. Weigang-Köhler, Olivia Pagani, et al.. (2002). Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule. European Journal of Cancer. 38(18). 2388–2396. 44 indexed citations

Borner, M., Patrick Schöffski, Ronald de Wit, et al.. (2002). Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin. European Journal of Cancer. 38(3). 349–358. 274 indexed citations

Smyth, John, Jan H.M. Schellens, Hilary Calvert, et al.. (2001). Activity of the dolastatin analogue, LU103793, in malignant melanoma. Annals of Oncology. 12(4). 509–511. 26 indexed citations

Eskens, Ferry A.L.M., G. Greim, Ingmar Wolff, et al.. (2000). Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors. European Organization for Research and Treatment of Cancer Early Clinical Studies Group.. PubMed. 6(5). 1736–43. 22 indexed citations

Schoenherr, U, et al.. (1985). [Bacterial colonization of the stomach caused by acid neutralization and inhibition of stomach emptying].. PubMed. 23(4). 169–74. 2 indexed citations

Greim, G., et al.. (1983). [Endogenous synthesis of carcinogenic N-nitroso compounds: bacterial flora and nitrite formation in the healthy human stomach].. PubMed. 178(4). 297–315. 3 indexed citations

Remmer, H., G. Greim, & Alfred G. Hildebrandt. (1968). Die spektralen Eigenschaften von Cytochrom-P450 nach Induktion mit Phenobarbital, Benzpyren und Methylcholanthren. Naunyn-Schmiedeberg s Archives of Pharmacology. 260(2-3). 189–190. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact